Co-Founder, CEO, and President
Dr. Venepalli has over over 35 years of experience working with fine chemicals. Before co-founding CiVentiChem in 1994, he spent 13 years with Eastman Kodak – Eastman Chemical Company working as manager of New Product and Business Development. Dr. Venepalli received his Ph.D. from Osmania University, Hyderabad (India) and did Post Doctoral Research at the University of Southampton (England) and Rockefeller University (New York). He received his MBA from the Simon Business School at the University of Rochester. Dr. Venepalli is a Board Member of the North Carolina Biotechnology Center.
Co-Founder and Managing Director
Dr. Chittineni has 28+ years experience in synthetic organic chemistry with expertise in Complex Organic Synthesis, Chiral, and Carbohydrate Chemistry. He currently leads CiVentiChem’s operations in Hyderabad, India. Dr. Chittineni received his Ph.D. from Kakatiya-
University (IICT, Hyderabad, India) and did his Post Doctoral Research at Duke University.
Tony is a career entrepreneur, investor, and executive in the Biopharma space having taken public, started, or managed seven companies. Prior to joining CiVentiChem in September 2014, Tony was President and CEO of Wisconsin based Cedarburg Pharmaceuticals since 2007.
Under Tony’s leadership Cedarburg grew significantly and was acquired by Albany Molecular Research, Inc. (NASDAQ: AMRI) in April 2014.